REFERENCES
- Institute of Medicine. Crossing the Quality Chasm: A New Health System for the Twenty-first Century. Washington: National Academies Press. 2001.
- OECD. Health expenditure and Financing. Health at a Glance: OECD Publishing. 2011.
- Stone PW, Braccia D, Larson E. Systematic review of economic analyses of health care-associated infections. Am J Infect Control 2005; 33: 501–509.
- European Centre for Disease prevention and Control. Annual epidemiological report on communicable diseases in Europe. Stockholm. 2008.
- Kaoutar B, Joly C, L'Heriteau F, et al. French Hosp Mortality Study G. Nosocomial infections and hospital mortality: a multicentre epidemiological study. J Hosp Infect 2004; 58: 268–275.
- Vrijens F, Hulstaert F, Devriese S, De Sande SV. Hospital-acquired infections in Belgian acute-care hospitals: an estimation of their global impact on mortality, length of stay and healthcare costs. Epidemiol/nfect 2012; 140: 126–136.
- Gordts B, Vrijens F, Hulstaert F, Devriese S, Van de Sande S. The 2007 Belgian national prevalence survey for hospital-acquired infections. J Hosp Infect 2010; 75: 163–167.
- Harbarth S, Sax H, Gastmeier P. The preventable proportion of nosocomial infec-tions: an overview of published reports. J Hosp Infect 2003; 54: 258–266.
- Umscheid CA, Mitchell MD, Doshi JA, Agarwal R, Williams K, Brennan PJ. Estimating the Proportion of Healthcare-Associated Infections That Are Reasonably Preventable and the Related Mortality and Costs. Infect Cont Hosp Ep 2011; 32: 101–114.
- International Classification of Diseases, ninth revision (ICD-9-CM). 2009.
- Pirson M, Dramaix M, Leclereq P, Jackson T. Analysis of cost outliers within APR-DRGs in a Belgian general hospital: Two complementary approaches. Health Policy 2006; 76: 13–25.
- CDC definitions, http://www.cdc.govincidod/dhqp/pdfinnis/NosInfDefinitions.pdf.
- Vrijens F, Gordts B, De Laet C, et al. Nosocomial Infections in Belgium, part I: national prevalence study. KCE reports. 2008; 92C
- Klevens RM, Edwards J, Richards C et al. Estimating Health Care-Associated Infections and Deaths in U.S. Hospitals. Public Health Reports 2007; 122: 160–166.
- Stone PW, Braccia D, Larson E. Systematic review of economic analyses of health care-associated infections. Am J infect Control 2005; 33: 501–509.
- Plowman R, Graves N, Griffin MAS et al. The rate and cost of hospital-acquired infections occurring in patients admitted to selected specialties of a district general hospital in England and the national burden imposed. J Hosp Infect 2001;47: 198–209.
- Chaix C, Durand-Zaleski I, Alberti C, Brun-Buisson C. Control of endemic methi-cillin-resistant Staphylococcus aureus - A cost-benefit analysis in an intensive care unit. J Am Med Assoc 1999; 282: 1745–1751.
- Vandijck DM, Blot SI, Decruyenaere JM et al. Costs and length of stay associated with antimicrobial resistance in acute kidney injury patients with bloodstream infection. Acta Clin Belg 2008; 63: 31–38.
- Al-Rawajfah OM, Hewitt JB, Stetzer F, Cheema J. Length of stay and charges associated with health care-acquired bloodstream infections. Am J Infect Control 2012; 40: 227–232.
- Borghans I, Heijink R, Kool T, Lagoe RJ, Westert GP. Benchmarking and reducing length of stay in Dutch hospitals. BMC Health Sent Res 2008; 8: 220.